Shattuck Labs, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Shattuck Labs, Inc. (STTK) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 201.43 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-11
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 12.81K shares, a 91.22% decline year-over-year.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 188.62K shares, a 62.99% decline year-over-year.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 38.90K shares, a 92.73% decline year-over-year.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 229.16K shares, a 305.28% increase year-over-year.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 923.51K shares, a 22.86% increase from fiscal 2024.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 751.70K shares, a 26.47% increase from fiscal 2023.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 594.37K shares, a 326.09% increase from fiscal 2022.
- Shattuck Labs, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 139.50K shares, a 127.16% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 12.81K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 201.43K shares 10-Q · filed 2026-08-11 | 240.33K shares derived: sum of 3 quarters · filed 2026-08-11 | 469.49K shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 188.62K shares 10-Q · filed 2026-05-07 | 227.52K shares derived: sum of 2 quarters · filed 2026-05-07 | 456.68K shares derived: sum of 3 quarters · filed 2026-05-07 | 602.53K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 38.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 268.06K shares derived: sum of 2 quarters · filed 2026-03-05 | 413.92K shares derived: sum of 3 quarters · filed 2026-03-05 | 923.51K shares 10-K · filed 2026-03-05 |
| 2025-09-30 | 229.16K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 375.02K shares derived: sum of 2 quarters · filed 2025-11-06 | 884.61K shares 10-Q · filed 2025-11-06 | 1.42M shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 145.86K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 655.45K shares 10-Q · filed 2025-08-14 | 1.19M shares derived: sum of 3 quarters · filed 2025-08-14 | 1.25M shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 509.59K shares 10-Q · filed 2025-05-01 | 1.04M shares derived: sum of 2 quarters · filed 2025-05-01 | 1.10M shares derived: sum of 3 quarters · filed 2025-05-01 | 1.14M shares derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-12-31 | 534.82K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 591.36K shares derived: sum of 2 quarters · filed 2025-03-27 | 632.88K shares derived: sum of 3 quarters · filed 2025-03-27 | 751.70K shares 10-K · filed 2025-03-27 |
| 2024-09-30 | 56.54K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 98.07K shares derived: sum of 2 quarters · filed 2024-11-14 | 216.89K shares 10-Q · filed 2024-11-14 | 508.78K shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | 41.52K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 160.34K shares 10-Q · filed 2024-08-01 | 452.24K shares derived: sum of 3 quarters · filed 2024-08-01 | 477.98K shares derived: sum of 4 quarters · filed 2024-08-01 |
| 2024-03-31 | 118.82K shares 10-Q · filed 2024-05-02 | 410.71K shares derived: sum of 2 quarters · filed 2024-05-02 | 436.45K shares derived: sum of 3 quarters · filed 2024-05-02 | 585.00K shares derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-12-31 | 291.89K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 317.64K shares derived: sum of 2 quarters · filed 2024-02-29 | 466.19K shares derived: sum of 3 quarters · filed 2024-02-29 | 594.37K shares 10-K · filed 2024-02-29 |
| 2023-09-30 | 25.74K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 174.29K shares derived: sum of 2 quarters · filed 2023-11-09 | 302.48K shares 10-Q · filed 2023-11-09 | 326.59K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 148.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 276.74K shares 10-Q · filed 2023-08-10 | 300.85K shares derived: sum of 3 quarters · filed 2023-08-10 | 369.44K shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 128.19K shares 10-Q · filed 2023-05-09 | 152.30K shares derived: sum of 2 quarters · filed 2023-05-09 | 220.89K shares derived: sum of 3 quarters · filed 2023-05-09 | 236.02K shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 24.11K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 92.70K shares derived: sum of 2 quarters · filed 2023-02-23 | 107.84K shares derived: sum of 3 quarters · filed 2023-02-23 | 139.50K shares 10-K · filed 2023-02-23 |
| 2022-09-30 | 68.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 83.72K shares derived: sum of 2 quarters · filed 2022-11-09 | 115.38K shares 10-Q · filed 2022-11-09 | 150.94K shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 15.13K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 46.79K shares 10-Q · filed 2022-08-11 | 82.36K shares derived: sum of 3 quarters · filed 2022-08-11 | 87.06K shares derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | 31.66K shares 10-Q · filed 2022-05-12 | 67.22K shares derived: sum of 2 quarters · filed 2022-05-12 | 71.92K shares derived: sum of 3 quarters · filed 2022-05-12 | 77.21K shares derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | 35.56K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 40.26K shares derived: sum of 2 quarters · filed 2022-03-15 | 45.55K shares derived: sum of 3 quarters · filed 2022-03-15 | 61.41K shares 10-K · filed 2022-03-15 |
| 2021-09-30 | 4.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 9.98K shares derived: sum of 2 quarters · filed 2021-11-09 | 25.85K shares 10-Q · filed 2021-11-09 | 30.98K shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | 5.29K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 21.15K shares 10-Q · filed 2021-08-12 | 26.29K shares derived: sum of 3 quarters · filed 2021-08-12 | |
| 2021-03-31 | 15.86K shares 10-Q · filed 2021-05-10 | 21.00K shares derived: sum of 2 quarters · filed 2021-05-10 | ||
| 2020-12-31 | 5.14K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 35.96K shares 10-K · filed 2021-03-16 | ||
| 2020-09-30 | 30.82K shares 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |